Vertex Under Pressure To Spend On M&A
Company Has $6.7bn In Cash
The biotech is growing fast thanks to its success in cystic fibrosis, but is under pressure to be bolder in its business development
The biotech is growing fast thanks to its success in cystic fibrosis, but is under pressure to be bolder in its business development